Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral

Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral

Yahoo Finance • Jan 15, 2026 • 1 min read
Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral

Sign in to read the full article.

Sign in with Google
Preview View Original

Settings

Appearance
API Keys